Puma Biotechnology Inc
PBYI
Get informed when a big investor buys or sells
+ FollowMarket Cap$407.2M
Close$
$17.47
111% upside
Current Fair Value
111% upsideUndervalued by 111% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $407.20 Million |
|---|---|
| Enterprise Value | $386.95 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.62 |
| Beta | 1.19 |
| Outstanding Shares | 50,845,130 |
Return
| Return on Equity | 18.92% |
|---|---|
| Return on Assets | 12.61% |
| Return on Invested Capital | 24.05% |
Valuation & Multiples
| P/E Ratio | 16.12 |
|---|---|
| PEG | -7.08 |
| Price to Sales | 2.07 |
| Price to Book Ratio | 4.14 |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 12.1 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$42.00 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.07
Average shareholder expectationRevenue Estimate
$53.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 111,100▲ 5.11% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 75.70%▲ 5.49% |
|---|---|
| Total Invested | $241.84M▲ 15.03% |
| Investors Holding | 159▲ 5.00% |
ESG Score
No data